blue cross blue shield glp 1 coverage 2026 BC/BS Health Insurance Change in Why Blue Cross Blue Shield
Description
Contact us today
Two m slices of formalin-fixed paraffin-embedded (FFPE) tissue were dyed with hematoxillin/eosin (H&E) for determination of metabolic dysfunction-associated fatty liver disease (MASLD) and chromotrope-anilin blue (CAB) trichrome staining for fibrosis assessment
In clinical trials, participants using Zepbound achieved an average weight loss of approximately 20.2% over 72 weeks, while those on Wegovy experienced about a 13.7% reduction
"FDA reports no link between weight-loss drugs and suicidal thoughts"
Yet the identity of the downstream signalling events mediated by these peptides remain to be elucidated
The most concerning immediate risk is hyperglycaemia (elevated blood glucose), which can develop within days of stopping treatment
